Imricor
Manufacturing · Minnesota, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
400 Gateway Blvd, Burnsville, Minnesota,...Phone Number
(952) 818-8400Website
www.imricor.comRevenue
<$5 MillionStock Symbol
IMRIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Imricor
Imricor is a medical technology company focused on developing and commercializing innovative MRI-compatible devices that enable physicians to perform cardiac catheter ablation procedures under real-time magnetic resonance imaging guidance, offering advanced solutions such as specialized catheters, mapping systems, and electrophysiology equipment designed to improve the precision, safety, and effectiveness of treating heart rhythm disorders while reducing reliance on traditional imaging methods, and supporting healthcare providers worldwide with integrated technologies that enhance clinical outcomes and advance the field of interventional cardiac care.Explore more
Imricor Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imricor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Imricor is spiking on competitors!
Funding: Get notified immidiatlly once Imricor has new funding data
Check if Imricor has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Imricor recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Imricor
Product Launch: Get notified when Imricor launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Imricor, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Imricor had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Imricor
Find 2 more new buyers
Compare Similar Companies to Imricor
Compare insights from companies similar to Imricor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Imricor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Imricor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Imricor.
Imricor financials insights
Gather financial insights about Imricor, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$1.6M
2026
Stock/Share Issuance
$43.1M
Imricor Tech Stack
A closer look at the technologies used by Imricor
Most Recent Scoops
Project
Imricor announced that the Academic Medical Center in Amsterdam is relocating to a new cardiology wing in September with a brand-new Philips IMR lab, enabling procedures to be performed in the regular course of business without reliance on shared MRI time from radiology, a development made possible by the Philips declaration of compatibility.
Healthcare Technology, Radiology
Project
Imricor has partnered with DLL Group to launch Imricor Finance, a vendor financing program that allows hospitals to spread capital equipment payments over one to seven years while Imricor receives full payment upfront with credit exposure carried by DLL Group.
Project
Imricor is advancing the VISABL-VT trial, a 64-patient study led by key opinion leaders Felix Hoendervanger and Gerhard Hindricks at the Charité in Berlin, with major US institutions including Virginia Commonwealth University, the University of Virginia, the Oklahoma Heart Institute, and Johns Hopkins identified as candidates for the trial upon completing VISABL-AFL enrollment.
Clinical Operations
Project
Imricor has secured four FDA clearances within six months, including clearance of the Vision-MR Diagnostic Catheter, NorthStar, and pediatric label expansions for both devices, enabling cleared US products to be used in patients of any age.
Medical Research
Project
Pharmaceuticals, Clinical Operations
Imricor News & Media
Institutions own 27% of Imricor Medical Systems, Inc. (ASX:IMR) shares but individual investors control 59% of the company
Key Insights Significant control over Imricor Medical Systems by individual investors implies that the general public...Imricor Commences VISABL-VT Trial
MINNEAPOLIS--(BUSINESS WIRE)-- #Cardiotwitter--Imricor announces that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time MRI.Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
MINNEAPOLIS--(BUSINESS WIRE)-- #CardioTwitter--Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr). Dr. Laurent Fiorina, the operating Electrophysiologist at ICPS and the site’s Pr
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imricor
Sign Up For FreeTo access detailed company insights
Imricor is a medical technology company focused on developing and commercializing innovative MRI-compatible devices that enable physicians to perform cardiac catheter ablation procedures under real-time magnetic resonance imaging guidance, offering advanced solutions such as specialized catheters, mapping systems, and electrophysiology equipment de... Read More
